Comparison of the efficacy of IGIV-C, 10% (caprylate/chromatography) and IGIV-SD, 10% as replacement therapy in primary immune deficiency A randomized double-blind trial
Pharmacology, Toxicology and Pharmaceutical Science
5
6%
Nursing and Health Professions
5
6%
Psychology
3
4%
Other
9
11%
Unknown
19
23%
Attention Score in Context
Attention Score in Context
This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 December 2021.
All research outputs
#6,087,087
of 27,780,120 outputs
Outputs from International Immunopharmacology
#662
of 4,728 outputs
Outputs of similar age
#11,780
of 60,468 outputs
Outputs of similar age from International Immunopharmacology
#3
of 27 outputs
Altmetric has tracked 27,780,120 research outputs across all sources so far. This one has received more attention than most of these and is in the 74th percentile.
So far Altmetric has tracked 4,728 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.6. This one has done well, scoring higher than 82% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 60,468 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.
We're also able to compare this research output to 27 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 62% of its contemporaries.
